Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $390.85M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.80% Avg Daily Range (30 D): $0.26 | 4.19% Avg Daily Range (90 D): $0.27 | 4.40% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .64M Avg Daily Volume (90 D): .68M Trade Size Avg Trade Size (Sh.): 134 Avg Trade Size (Sh.) (30 D): 79 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 633 Avg Inst. Trade: $1.62M Avg Inst. Trade (30 D): $1.27M Avg Inst. Trade (90 D): $.88M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.64M Avg Closing Trade (30 D): $1.53M Avg Closing Trade (90 D): $.91M Avg Closing Volume: 128.42K         News May 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Apr 30, 2025 @ 11:00 AM EyePoint to Report First Quarter 2025 Financial Re... Source: N/A Apr 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Mar 27, 2025 @ 11:00 AM EyePoint to Present at 2025 RBC Capital Markets Op... Source: N/A Feb 17, 2025 @ 12:00 PM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Financials   TTM Q4 2024 FY 2024 Basic EPS $-.65 $-.65 $-2.32 Diluted EPS $-.65 $-.65 $-2.32 Revenue $ 24.45M $ 11.59M $ 43.27M Gross Profit $ $ $ Net Income / Loss $ -45.2M $ -41.4M $ -130.87M Operating Income / Loss $ -48.84M $ -45.24M $ -145.85M Cost of Revenue $ $ $ Net Cash Flow $ -14.55M $ 19.87M $ -181.56M PE Ratio     Splits Dec 09, 2020:   1:10 Jun 11, 2008:   1:4